oa Journal of Endocrinology, Metabolism and Diabetes in South Africa - Product news
Extracted from text ... JEMDSA 44 The INITIATE study: NovoMix 30 shows improved blood glucose control compared with insulin glargine NovoMix 30, a premix insulin analogue, is more effective than insulin glargine in helping people with type 2 diabetes, who are new to insulin therapy, achieve targeted HbA1c levels, according to a study published in the February issue of Diabetes Care. A total of 66% of patients using NovoMix 30 reached target HbA1c levels, compared with only 40% receiving insulin glargine. 'This study demonstrates the value of initiating insulin therapy with a dualacting insulin analogue, particularly in patients with HbA1c values greater than 8.5%, ..
Article metrics loading...